Grundinformationen
- Standard-SMILES
Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1.O=[N+]([O-])O- InChIKey
HAAITRDZHUANGT-UHFFFAOYSA-N- Summenformel
- C20H16Cl3N3O4S
- Durchschnittliche Molmasse
- 500,8 g/mol
- Monoisotopische Masse
- 498,99271003
Überblick
Sertaconazole Nitrate is the nitrate salt form of sertaconazole, a synthetic imidazole derivative with antifungal property. Sertaconazole nitrate inhibits fungal cytochrome P-450 sterol C-14 alpha-demethylation, resulting in the accumulation of fungal 14 alpha-methyl sterols and the inhibition of ergosterol synthesis, an essential component of the cell membrane of fungi. This leads to a disruption of cell membrane permeability and leakage of adenine triphosphate (ATP) and other constituents from fugal cells.
Namen und Bezeichner
- Bevorzugter Name
- Sertaconazole Nitrate
- IUPAC
- 1-[2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole;nitric acid
- Englischer Name
- Sertaconazole nitrate
- Summenformel
- C20H15Cl3N2OS.HNO3
- Molmasse
- 500.78
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
99592-39-9- PubChem CID
- 200103
- DTXSID
DTXSID2045529- ChEMBL
CHEMBL1200725- UNII
- 1DV05410M5
- EC Number
- 893-241-3
Eigenschaften
Berechnete Struktureigenschaften
- Polarare Oberfläche (TPSA)
- 121 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 6
- Frei drehbare Bindungen
- 6
- Schwere Atome
- 31
- Formalladung
- 0
- Komplexität
- 513
Experimentelle und physikochemische Eigenschaften
Human Drugs
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
Physikochemische Eigenschaften
- Schmelzpunkt
- 158 · 158-160°
- storage temp.
- -20 °C · -20°C
- Löslichkeit
- 20 mg/mL, · DMSO: soluble20mg/mL, clear
- pka
- 7.26 · pKb: 7.26(at 25℃)
- Aggregatzustand
- powder
- Farbe
- white to beige
- InChI
- 1S/C20H15Cl3N2OS.HNO3/c21-14-4-5-16(18(23)8-14)19(9-25-7-6-24-12-25)26-10-13-11-27-20-15(13)2-1-3-17(20)22;2-1(3)4/h1-8,11-12,19H,9-10H2;(H,2,3,4)
- InChIKey
- HAAITRDZHUANGT-UHFFFAOYSA-N
- SMILES
- [s]1c2c(c(c1)COC(C[n]4cncc4)c3c(cc(cc3)Cl)Cl)cccc2Cl.[N+](=O)([O-])O
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Gefahrenhinweise
Toxikologische Informationen
Toxicity Summary
Sertaconazole interacts with 14-α demethylase, a cytochrome P-450 enzyme necessary to convert lanosterol to ergosterol. As ergosterol is an essential component of the fungal cell membrane, inhibition of its synthesis results in increased cellular permeability causing leakage of cellular contents. Sertaconazole may also inhibit endogenous respiration, interact with membrane phospholipids, inhibit the transformation of yeasts to mycelial forms, inhibit purine uptake, and impair triglyceride and/or phospholipid biosynthesis.
Sicherheitsdaten
- wgk
- 3
- Speicherklasse
- 11 - Combustible Solids
- Hazard Classifications
- Repr. 2
Chemie und Industrie
Pharmakologische Informationen
FDA Pharmacological Classification
SERTACONAZOLE NITRATE
Azoles [CS]; Azole Antifungal [EPC]
Verwendung und Herstellung
Anwendungen
BeschreibungSertaconazole nitrate is a new broad spectrum imidazole antifungal agent introduced in a topical formulation for the treatment of cutaneous infections. Its mechanism of action is the inhibition of ergosterol synthesis and interference with the permeability of fungus cell membranes. An oral formulation is currently under investigation for the treatment of bucco-pharyngeal fungal infections.
VerwendenAn imidazole antifungal agent, inhibits the synthesis of ergosterol, an essential cell wall component of fungi.
Anbieter50 Anbieter
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…